MPS5202
From ideas to medicines: Investigator perspectives
基本信息
| 学分 | 6 credit points |
|---|---|
| 开课学期 | Second semester |
| 校区 | Malaysia |
| 考核构成 | Team report 2 — 25% Viva — 35% Workshop submissions — 20% Team report 1 — 10% Reflection on learning — 10% |
开课安排1 条
| 教学期 | 授课方式 | 状态 |
|---|---|---|
| Second semester | Teaching activities are on-campus (ON-CAMPUS) | 开课 |
以上为该校区在官方资料中登记的全部开课安排，不是汇总。同一门课可能在多个 教学期开课，也可能不同教学期的授课方式不同。
课程简介
This unit takes you into the minds of leading researchers in the pharmaceutical sciences to unravel the thinking that goes into transforming an idea into a clinically useful drug. From a series of recorded and live interviews and Q&A sessions with the investigators, you will be able to interrogate research leaders on the qualities they possess and the strategies they use to help them generate ideas, test hypotheses and guide research programs whose primary aim is the discovery and development of new medicines.
Working in groups and individually, you will critically examine four investigator-driven drug discovery and development examples and, from your enquiry, formulate a comprehensive dossier on the interplay of science, scientists and prevailing circumstances in pharmaceutical discovery. You will present your findings, including ethical and sustainability issues that you encounter, in a variety of written and oral modalities. Upon completing this unit, you will have a mature understanding of the human nature of pharmaceutical research which will allow you to holistically evaluate contemporary and future pharmaceutical endeavours.
以上为 Monash Handbook 的官方原文，版权属 Monash University，此处按本站要求转载并标注出处： 官方页面 ↗
学习成果6 条
官方原文（Learning outcomes），版权属 Monash University。
- ULO1 Critically evaluate the role of the investigator in specific examples of drug discovery and development
- ULO2 Present a logical and nuanced analysis of how scientific, ethical and commercial considerations inform decision-making in specific examples of drug development
- ULO3 Predict how the presence of contemporary technologies – had they been available at the time – might have influenced the approaches and strategies chosen by investigators to develop specific pharmaceutical products in the past
- ULO4 Use effective oral communication to present an informed evaluation of the specific examples of investigator-driven pharmaceutical research
- ULO5 Demonstrate effective teamwork practices within the context of a group report
- ULO6 Develop communication and critical thinking skills via effective reflective practice.
教学方式与预期工作量
教学方式
Enquiry-based learning
Peer assisted learning
Active learning
Case-based teaching
Online learning
预期工作量
• 24 hours of preparation for classes
• Twelve 3-hour workshops
• 72 hours of independent study
• 12 hours of group work
官方原文，版权属 Monash University。
先修 / 同修要求
官方资料未列出该课程的先修要求。
先修链路
官方资料未列出该课程的先修要求，因此没有链路可画。
属于这些学位1 个
这门课出现在下列学位的官方结构里。反过来说：如果你读的是这些学位之一，它大概率是要修的 （必修还是选修取决于它在 Part 里的位置，点进去看结构）。
数据来源
- 数据来源
- 官方网页
handbook.monash.edu ↗ - 抓取时间
- 2026-09-13
- 可信度
- 程序抓取，未人工核实
查看官方完整描述 ↗ — 事实性字段（代码、学分、教学期、授课方式、考核权重、先修/同修/互斥关系）与 课程简介、学习成果、教学方式、预期工作量均取自官方 Handbook； 正文版权属 Monash University，此处转载并逐处标注出处。
发现信息有误？告诉我们。请用自己的话描述问题，不要上传成绩单、截图或校内系统文件。